查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829373

2025年全球呼吸吸入设备市场报告

Respiratory Inhaler Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，呼吸吸入设备市场呈现强劲成长势头，市场规模从2024年的413.5亿美元成长至2025年的439.8亿美元，复合年增长率达6.4%。过去的成长主要归因于吸烟盛行、过敏性疾病、药物创新和人口老化等因素。

预计未来几年呼吸吸入设备市场规模将强劲成长，到2029年将达到591.1亿美元，复合年增长率为7.7%。预测期内的成长可归因于空气品质问题、数位健康整合、对吸入器安全性的监管关注以及个人化治疗。预测期内的主要趋势包括吸入器设备的小型化、永续性和环保吸入器、居家照护以及技术进步。

呼吸吸入装置是一种紧凑的手持式工具，旨在将药物直接输送至肺部。它们专门设计用于将药物输送至呼吸系统（主要透过肺部），最大限度地减少全身药物效应，并在呼吸道疾病发作和加重期间提供快速缓解。

呼吸吸入器产品的主要类别包括干粉吸入器 (DPI)、定量喷雾吸入器和雾化器。干粉吸入器是一种将粉末药物直接输送到肺部以治疗呼吸系统疾病的医疗设备。这些吸入器有手动和电子两种形式。 DPI 通常用于治疗气喘、慢性阻塞性肺病(COPD)、肺动脉高血压和其他呼吸系统疾病。呼吸吸入器设备用于各种医疗保健场所，包括医院、诊所、呼吸照护中心和其他医疗机构。它们已成为实施呼吸治疗和管理呼吸系统疾病的重要工具。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供呼吸吸入设备市场统计数据，其中包含您在呼吸吸入设备行业取得成功所需的所有数据，包括全球市场规模、区域份额、竞争对手的市场份额、详细的呼吸吸入设备细分市场、市场趋势和商机。本呼吸吸入设备市场研究报告对该行业的现状和未来走势进行了详细分析，以全面的观点为您提供所需的所有资讯。

我们对该市场未来五年7.7%的成长率预测与先前的预测一致。下降的主要原因是美国与其他国家之间关税的影响。这种影响可能会对美国产生直接影响，导致计量阀组件和干粉分散装置的成本上升（这些产品主要从英国和瑞士进口），从而导致气喘和慢性阻塞性肺病(COPD) 治疗药物的价格上涨。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响，这种影响也将更加广泛。

呼吸系统疾病的发生率正在上升，这将推动呼吸吸入设备市场的成长。呼吸系统疾病包括影响肺部和呼吸系统的多种疾病，常常导致呼吸困难和肺功能下降。这些疾病包括气喘、慢性阻塞性肺病(COPD)、呼吸道融合细胞病毒感染疾病和各种其他呼吸系统疾病。呼吸吸入装置的使用对于将药物直接输送到肺部并为与呼吸系统疾病作斗争的人们提供快速准确的缓解至关重要。例如，美国着名公共卫生组织疾病管制与预防中心最近的数据显示，美国报告的结核病病例预计将从 2021 年的 7,874 例增加到 2022 年的 8,300 例。这些数据凸显了呼吸系统疾病发病率不断上升带来的巨大动力，这将推动呼吸吸入设备市场的扩张。

预计吸烟率上升将在未来几年推动呼吸吸入设备市场的成长。吸烟包括吸入和呼出燃烧烟草和其他物质产生的蒸气，会损害肺部的气道和微小气囊（肺泡），可能导致气喘、慢性阻塞性肺病和支气管炎等呼吸系统疾病。呼吸吸入装置对于缓解症状和防止进一步呼吸困难来控制这些疾病至关重要。例如，2024 年 9 月，美国政府机构疾病管制与预防中心 (CDC) 报告称，烟草使用仍然是美国可预防疾病和死亡的主要原因。到 2022 年，约有 4,920 万成年人（19.8%）或近五分之一的人报告使用烟草製品。因此，吸烟率上升正在推动呼吸吸入设备市场的成长。

呼吸吸入设备市场的主要企业正越来越多地采用定量喷雾吸入器(MDI) 等先进技术来巩固其市场地位。 MDI 是一种携带式气雾剂设备，旨在以吸入雾或喷雾的形式向肺部输送精确的药物剂量。例如，2022 年 2 月，专门生产消费者分配包装和药物传输设备的美国製造商 AptarGroup Inc. 推出了 HeroTracker Sense。这种创新的数位呼吸健康解决方案有效地将传统的定量喷雾吸入器(pMDI) 转变为智慧互联的医疗设备。 HeroTracker Sense 监测患者对 MDI 的使用情况，促进更好地遵守配方治疗，并最终改善全球与气喘、慢性阻塞性肺病(COPD)、囊肿纤维化和 COVID-19 引起的呼吸系统併发症等慢性呼吸系统疾病作斗争的个人的生活。 HeroTracker Sense 也透过 Aptar Pharma Cohero Health BreatheSmart Connect 入口网站为医疗保健提供者 (HCP) 提供有关患者培训、入职和绩效的宝贵分析和见解。

2022年8月，总部位于美国、专注于消费性药品包装和药物输送设备的製造商AptarGroup Inc.透过收购Pharmaxis Ltd.，获得了Orbital Inhaler的全球权利。此次对Orbital Inhaler权利的策略性收购，与Aptar Pharma的使命相契合，即扩展其呼吸设备产品组合，并为呼吸系统疾病患者提供创新解决方案。 Pharmaxis Ltd.是一家总部位于澳洲、专注于临床阶段的製药公司，开发了突破性的Orbital Dry Powder Inhaler。这项策略性收购彰显了Aptar Pharma致力于推进呼吸照护的决心。

呼吸吸入设备市场由提供诸如管理慢性肺部疾病和最大程度减轻药物全身影响等服务的营业单位所赚取的收益构成。市场规模还包括服务提供者销售或包含在其服务产品中的相关产品的价值。呼吸吸入设备市场还包括压缩空气雾化器、超音波雾化器和网状雾化器的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球呼吸吸入设备：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球呼吸吸入设备市场：成长率分析
  • 全球呼吸吸入设备市场表现：规模与成长，2019-2024
  • 全球呼吸吸入设备市场预测：规模与成长，2024-2029年，2034年
  • 全球呼吸吸入设备：总目标市场（TAM）

第六章 市场细分

  • 全球呼吸吸入设备市场（按产品、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 干粉吸入器
  • 定量喷雾吸入器
  • 喷雾器
  • 全球呼吸吸入设备市场技术、效能及预测（2019-2024、2024-2029、2034）
  • 手动吸入器
  • 数位吸入器
  • 全球呼吸吸入设备市场（依疾病适应症、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 气喘
  • 慢性阻塞性肺病
  • 肺动脉高血压
  • 其他的
  • 全球呼吸吸入设备市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 呼吸护理中心
  • 其他的
  • 全球呼吸吸入器设备市场：干粉吸入器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量吸入器
  • 多剂量吸入器
  • 全球呼吸吸入器设备市场：定量喷雾吸入器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 含氯氟烃的MDI
  • 基于HFA的MDI
  • 全球呼吸吸入设备市场：雾化器细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 喷射雾化器
  • 超音波雾化器
  • 网状雾化器

第七章 区域和国家分析

  • 全球呼吸吸入设备市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球呼吸吸入设备市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 呼吸吸入器市场：竞争格局
  • 呼吸吸入设备市场：公司简介
    • Merck & Co. Inc.
    • Novartis AG
    • AstraZeneca plc
    • Gerresheimer AG
    • GlaxoSmithKline plc

第31章：其他领先和创新企业

  • 3M
  • Boehringer Ingelheim International GmbH
  • Koninklijke Philips NV
  • Viatris Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Catalent Inc.
  • Perrigo Company plc
  • AptarGroup Inc.
  • Recipharm AB
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • Hikma Pharmaceuticals plc
  • Zydus Lifesciences Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年呼吸吸入设备市场：提供新机会的国家
  • 2029年呼吸吸入设备市场：细分市场带来新机会
  • 2029年呼吸吸入设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r28885u

Respiratory inhaler devices are compact, handheld tools designed to administer medication directly to the lungs. They are specifically engineered to deliver medications to the respiratory system, with a focus on the lungs, which helps minimize systemic drug effects and provides rapid relief during respiratory attacks or exacerbations.

The primary categories of respiratory inhaler device products include dry powder inhalers, metered dose inhalers, and nebulizers. Dry powder inhalers (DPIs) are medical devices that dispense powdered medications directly to the lungs for the treatment of respiratory conditions. These inhaler devices encompass both manually operated and digitally operated options. They are commonly used in the management of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary arterial hypertension, and other respiratory issues. Respiratory inhaler devices find application in various healthcare settings, including hospitals, clinics, respiratory care centers, and other medical facilities. They serve as important tools for the delivery of respiratory medications and the management of respiratory conditions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The respiratory inhaler devices market research report is one of a series of new reports from The Business Research Company that provides respiratory inhaler devices market statistics, including respiratory inhaler devices industry global market size, regional shares, competitors with a respiratory inhaler devices market share, detailed respiratory inhaler devices market segments, market trends and opportunities and any further data you may need to thrive in the respiratory inhaler devices industry. This respiratory inhaler devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The respiratory inhaler devices market size has grown strongly in recent years. It will grow from $41.35 billion in 2024 to $43.98 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to smoking epidemic, allergic disorders, pharmaceutical innovation, aging population.

The respiratory inhaler devices market size is expected to see strong growth in the next few years. It will grow to $59.11 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to air quality concerns, digital health integration, regulatory emphasis on inhaler safety, personalized treatment. Major trends in the forecast period include inhaler device miniaturization, sustainability and eco-friendly inhalers, home-based care, technological advancements.

The forecast of 7.7% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through increased costs for metered-dose valve assemblies and dry powder dispersion mechanisms, primarily imported from the UK and Switzerland, leading to higher prices for asthma and chronic obstructive pulmonary disease (COPD) treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The prevalence of respiratory diseases is on the rise, and this phenomenon is poised to steer the growth of the respiratory inhaler devices market. Respiratory diseases encompass a spectrum of disorders that affect the lungs and the respiratory system, often resulting in breathing difficulties and compromised lung function. These conditions include ailments like asthma, chronic obstructive pulmonary disease (COPD), respiratory syncytial virus infection, and various other respiratory disorders. The utilization of respiratory inhaler devices is essential in delivering medications directly to the lungs, providing swift and precise relief for individuals battling respiratory illnesses. As an example, recent data from the Centers for Disease Control and Prevention, a prominent US-based public health organization, revealed an increase in tuberculosis (TB) cases reported in the United States, reaching 8,300 cases in 2022, up from 7,874 cases in 2021. This data underscores the significant impetus resulting from the growing prevalence of respiratory diseases, which propels the expansion of the respiratory inhaler devices market.

The rising smoking rates are expected to drive the growth of the respiratory inhaler devices market in the coming years. Smoking, which involves inhaling and exhaling the vapors of burning tobacco or other substances, can damage the airways and small air sacs (alveoli) in the lungs, leading to respiratory diseases such as asthma, COPD, and bronchitis. Respiratory inhaler devices are crucial for managing these conditions by alleviating symptoms and preventing further breathing difficulties. For instance, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that tobacco use remains the leading cause of preventable disease and death in the United States. In 2022, about 49.2 million adults, or 19.8%, nearly 1 in 5, reported using tobacco products. As a result, the increasing smoking rates are driving the growth of the respiratory inhaler devices market.

Prominent companies within the respiratory inhaler devices market are increasingly adopting advanced technologies, such as metered dosage inhalers (MDIs), to fortify their market standing. MDIs represent portable aerosol devices designed to deliver precise medication doses to the lungs in the form of an inhaled mist or spray. For instance, a noteworthy development occurred in February 2022, when AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, introduced HeroTracker Sense. This innovative digital respiratory health solution effectively transforms conventional metered dosage inhalers (pMDIs) into intelligent and connected medical devices. HeroTracker Sense aims to monitor the utilization of MDIs by patients, promoting better adherence to prescribed therapies and ultimately enhancing the lives of individuals worldwide grappling with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and respiratory complications triggered by COVID-19. HeroTracker Sense further offers invaluable analytics and insights related to patient training, onboarding, and performance, serving healthcare providers (HCPs) through the Aptar Pharma Cohero Health BreatheSmart Connect portal.

In August 2022, AptarGroup Inc., a US-based manufacturer specializing in consumer dispensing packaging and drug delivery devices, secured the global rights to the Orbital inhaler through an acquisition from Pharmaxis Ltd. This strategic acquisition of the Orbital inhaler rights aligns with Aptar Pharma's mission to expand its respiratory device portfolio and provide innovative solutions catering to patients grappling with respiratory conditions. Pharmaxis Ltd., an Australian-based pharmaceutical company with a clinical-stage focus, developed the groundbreaking Orbital dry powder inhaler. This strategic acquisition demonstrates a commitment to advancing respiratory care.

Major companies operating in the respiratory inhaler devices market are Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Gerresheimer AG, GlaxoSmithKline PLC, 3M, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., Perrigo Company PLC, AptarGroup Inc., Recipharm AB, Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Orion Corporation, Sumitomo Pharma America Inc., Beximco Pharmaceuticals Ltd., Hovione Limited, Vectura Group Limited, H&T Presspart Manufacturing Ltd., Pari Medical Holding GmbH, OMRON Healthcare Europe B.V., Medisol Lifescience Pvt. Ltd., Consort Medical plc.

North America was the largest region in the respiratory inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory inhaler devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the respiratory inhaler devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory inhaler devices market consists of revenues earned by entities by providing services such as the management of chronic lung diseases and minimizing systemic effects of the drugs. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory inhaler devices market also includes sales of compressed air nebulizers, ultrasonic nebulizers and mesh nebulizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Inhaler Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory inhaler devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory inhaler devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory inhaler devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Dry Powder Inhalers; Metered Dose Inhalers; Nebulizers
  • 2) By Technology: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Disease Indication: Asthma; Chronic Obstructive Pulmonary Disease; Pulmonary Arterial Hypertension; Other Indications
  • 4) By End User: Hospitals And Clinics; Respiratory Care Centers; Other End Users
  • Subsegments:
  • 1) By Dry Powder Inhalers: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Metered Dose Inhalers: CFC-Based MDIs; HFA-Based MDIs
  • 3) By Nebulizers: Jet Nebulizers; Ultrasonic Nebulizers; Mesh Nebulizers
  • Companies Mentioned: Merck & Co. Inc.; Novartis AG; AstraZeneca plc; Gerresheimer AG; GlaxoSmithKline plc; 3M; Boehringer Ingelheim International GmbH; Koninklijke Philips N.V.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Catalent Inc.; Perrigo Company plc; AptarGroup Inc.; Recipharm AB; Chiesi Farmaceutici S.p.A.; Cipla Limited; Hikma Pharmaceuticals plc; Zydus Lifesciences Limited; Lupin Limited; Glenmark Pharmaceuticals Ltd.; Orion Corporation; Sumitomo Pharma America Inc.; Beximco Pharmaceuticals Ltd.; Hovione Limited; Vectura Group Limited; H&T Presspart Manufacturing Ltd.; Pari Medical Holding GmbH; OMRON Healthcare Europe B.V.; Medisol Lifescience Pvt. Ltd.; Consort Medical plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Inhaler Devices Market Characteristics

3. Respiratory Inhaler Devices Market Trends And Strategies

4. Respiratory Inhaler Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Inhaler Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Inhaler Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Inhaler Devices Market Growth Rate Analysis
  • 5.4. Global Respiratory Inhaler Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Inhaler Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Inhaler Devices Total Addressable Market (TAM)

6. Respiratory Inhaler Devices Market Segmentation

  • 6.1. Global Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
  • 6.2. Global Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Other Indications
  • 6.4. Global Respiratory Inhaler Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Respiratory Care Centers
  • Other End Users
  • 6.5. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Dry Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.6. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • CFC-Based MDIs
  • HFA-Based MDIs
  • 6.7. Global Respiratory Inhaler Devices Market, Sub-Segmentation Of Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

7. Respiratory Inhaler Devices Market Regional And Country Analysis

  • 7.1. Global Respiratory Inhaler Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Inhaler Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Inhaler Devices Market

  • 8.1. Asia-Pacific Respiratory Inhaler Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Inhaler Devices Market

  • 9.1. China Respiratory Inhaler Devices Market Overview
  • 9.2. China Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Inhaler Devices Market

  • 10.1. India Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Inhaler Devices Market

  • 11.1. Japan Respiratory Inhaler Devices Market Overview
  • 11.2. Japan Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Inhaler Devices Market

  • 12.1. Australia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Inhaler Devices Market

  • 13.1. Indonesia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Inhaler Devices Market

  • 14.1. South Korea Respiratory Inhaler Devices Market Overview
  • 14.2. South Korea Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Inhaler Devices Market

  • 15.1. Western Europe Respiratory Inhaler Devices Market Overview
  • 15.2. Western Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Inhaler Devices Market

  • 16.1. UK Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Inhaler Devices Market

  • 17.1. Germany Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Inhaler Devices Market

  • 18.1. France Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Inhaler Devices Market

  • 19.1. Italy Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Inhaler Devices Market

  • 20.1. Spain Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Inhaler Devices Market

  • 21.1. Eastern Europe Respiratory Inhaler Devices Market Overview
  • 21.2. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Inhaler Devices Market

  • 22.1. Russia Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Inhaler Devices Market

  • 23.1. North America Respiratory Inhaler Devices Market Overview
  • 23.2. North America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Inhaler Devices Market

  • 24.1. USA Respiratory Inhaler Devices Market Overview
  • 24.2. USA Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Inhaler Devices Market

  • 25.1. Canada Respiratory Inhaler Devices Market Overview
  • 25.2. Canada Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Inhaler Devices Market

  • 26.1. South America Respiratory Inhaler Devices Market Overview
  • 26.2. South America Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Inhaler Devices Market

  • 27.1. Brazil Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Inhaler Devices Market

  • 28.1. Middle East Respiratory Inhaler Devices Market Overview
  • 28.2. Middle East Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Inhaler Devices Market

  • 29.1. Africa Respiratory Inhaler Devices Market Overview
  • 29.2. Africa Respiratory Inhaler Devices Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Inhaler Devices Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Inhaler Devices Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Inhaler Devices Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Inhaler Devices Market Competitive Landscape
  • 30.2. Respiratory Inhaler Devices Market Company Profiles
    • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Inhaler Devices Market Other Major And Innovative Companies

  • 31.1. 3M
  • 31.2. Boehringer Ingelheim International GmbH
  • 31.3. Koninklijke Philips N.V.
  • 31.4. Viatris Inc.
  • 31.5. Teva Pharmaceutical Industries Ltd.
  • 31.6. Catalent Inc.
  • 31.7. Perrigo Company plc
  • 31.8. AptarGroup Inc.
  • 31.9. Recipharm AB
  • 31.10. Chiesi Farmaceutici S.p.A.
  • 31.11. Cipla Limited
  • 31.12. Hikma Pharmaceuticals plc
  • 31.13. Zydus Lifesciences Limited
  • 31.14. Lupin Limited
  • 31.15. Glenmark Pharmaceuticals Ltd.

32. Global Respiratory Inhaler Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Inhaler Devices Market

34. Recent Developments In The Respiratory Inhaler Devices Market

35. Respiratory Inhaler Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Inhaler Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Inhaler Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Inhaler Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer